Alkermes' Corporate Presentation to be Webcast at the Jefferies 2018 Healthcare Conference

Alkermes' Corporate Presentation to be Webcast at the Jefferies 2018 Healthcare Conference

PR Newswire

DUBLIN, May 29, 2018 /PRNewswire/ -- Alkermes plc ALKS announced today that its corporate presentation will be webcast live at the Jefferies 2018 Healthcare Conference on Tuesday, June 5, 2018 at 1:30 p.m. ET (6:30 p.m. BST) from New York. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact: 

Jennifer Zibuda 

Investor Relations

+1 781 609 6129

Alkermes plc Logo (PRNewsfoto/Alkermes plc)

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/alkermes-corporate-presentation-to-be-webcast-at-the-jefferies-2018-healthcare-conference-300655834.html

SOURCE Alkermes plc

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press ReleasesConference Call Announcementstrade shows
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!